4.6 Article

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics

期刊

ARABIAN JOURNAL OF CHEMISTRY
卷 14, 期 8, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.arabjc.2021.103300

关键词

Amiodarone; Dronedarone; Pharmacokinetics; UPLC-MS; MS; Rat plasma

向作者/读者索取更多资源

The experiment established a method for analyzing specific drug concentrations and metabolites in rat plasma, and studied their pharmacokinetic characteristics. The method showed good linearity, sensitivity, and accuracy, suitable for determining pharmacokinetic parameters of specific drugs in rats.
The purpose of the experiment was mainly to establish and verify a precise and straightforward ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) approach for simultaneously analyzing the concentration levels of amiodarone, dronedarone, and their metabolites (desethylamiodarone and desbutyldronedarone) in the plasma of SpragueDawley (SD) rats and to investigate the pharmacokinetics of all analytes in SD rats. After rapid protein precipitation by using acetonitrile, we accomplished the chromatographic separation of amiodarone, desethylamiodarone, dronedarone, desbutyldronedarone and ivabradine (internal standard, IS) by using Acquity BEH C18 column and detected through a mass spectrometer with Xevo TQ-S triple quadrupole tandem, choosing the positive ion mode. The approach showed wonderful linearity, and the range of calibration curve for amiodarone was 1-200 ng/mL, desethylamiodarone was 0.1-20 ng/mL, dronedarone was 0.5-100 ng/mL, and desbutyldronedarone was 0.25- 50 ng/mL, respectively. For lower limit of quantification (LLOQ), the current method of UPLCMS/MS can achieve values of 1.0 ng/mL for amiodarone, 0.1 ng/mL for desethylamiodarone, 0.5 ng/mL for dronedarone, and 0.25 ng/mL for desbutyldronedarone, respectively. The accuracy of intra-day and inter-day of all analytes was between-14.8% to 10.9%, while the precision was < 13.3%. For each substance, the recovery rate was > 82.1%, besides, obvious matrix effect was not found. In all conditions, the stability of all analytes was comfirmed to the plasma sample quantification. In addition, the method of UPLC-MS/MS we developed could also be applied to measure the pharmacokinetic characteristics including amiodarone, desethylamiodarone, dronedarone, and desbutyldronedarone in the plasma of SD rats. (c) 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据